Alvina Okafor, PharmD
Sanofi/HUPIF
Global Regulatory Affairs Labeling Postdoctoral Fellow

Talk about diversity, equity, and inclusion in the pharmaceutical industry; what should companies be doing to continue making progress?

Diversity, equity, and inclusion in the pharmaceutical industry are essential for fostering innovation and ensuring that therapies meet the needs of diverse patient populations. To continue making progress, companies should invest in regions with high disease burdens, deeply study how those conditions affect local populations, and use those insights to develop more effective, equitable interventions.